Special Issue "Long-Term Effects of Systemic Therapies on Cancer Patients"
A special issue of Current Oncology (ISSN 1718-7729).
Deadline for manuscript submissions: 31 October 2021.
Chemotherapy and hormonal therapy have been the cornerstone of systemic therapy for cancer patients for the past 70 years, while, more recently, targeted therapy, monoclonal antibody therapy, and immunotherapy have seen significant increases in use. Given the increasing incidence of cancer, the changing age demographics of the affected population, the increased indications for therapies in earlier stages of disease, and the increased efficacy of recent therapies, there is a growing number of long-term survivors who have been treated with systemic chemotherapy, immunotherapy, hormonal therapy, and targeted therapy. This Special Issue focuses on the long-term effects of these therapies that require special attention in cancer survivors.
Dr. Andrew G. Robinson
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- late effects
- targeted therapy
- chemotherapy hormonal therapy